Company / Current Assets
Aquestive Therapeutics, Inc. Current Assets History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$149.3M
FY2025
5-year range
$39.9M / $149.3M
FY2021-FY2025
Trend
+69.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets has increased for 3 consecutive years, from $40M in FY2022 to $149M in FY2025.
Based on SEC 10-K filings.
$149M in FY2025 with a 5-year CAGR of +27.3%.
Improved from $41M to $149M over the past 2 years.
Current Assets over time
Growth rates
- 3-Year CAGR
- +55.3%
- 5-Year CAGR
- +27.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- Aquestive Therapeutics, Inc.'s current assets has grown for 3 consecutive years.
- 5-year CAGR of +27.3%, indicating consistent growth.
- In FY2025, current assets increased 69.2% year-over-year.
- Lowest current assets in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $149.3M | +69.2% |
| FY2024 | $88.2M | +115.3% |
| FY2023 | $41.0M | +2.7% |
| FY2022 | $39.9M | -15.6% |
| FY2021 | $47.3M | +5.9% |
| FY2020 | $44.6M | -34.7% |
| FY2019 | $68.3M | -7.9% |
| FY2018 | $74.2M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026